Serum SPARC and Matrix Metalloproteinase-2 and Metalloproteinase-9 Concentrations after Bariatric Surgery in Obese Adults

被引：0
作者：
Yeon Ji Lee
Yoon-Seok Heo
Hye Soon Park
Seoung Hee Lee
Seul Ki Lee
Yeon Jin Jang
机构：
[1] Inha University,Department of Family Medicine, College of Medicine
[2] Inha University,Department of General Surgery, College of Medicine
[3] University of Ulsan College of Medicine,Department of Family Medicine
[4] University of Ulsan College of Medicine,Department of Physiology
来源：
Obesity Surgery | 2014年 / 24卷
关键词：
Serum SPARC concentration; MMP-2; MMP-9; Bariatric surgery;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：604 / 610
页数：6
相关论文
共 50 条
[21]   Prognostic value of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and aminopeptidase N/CD13 in breast cancer patients [J].
Irena Ranogajec ;
Jasminka Jakić-Razumović ;
Velibor Puzović ;
Jelka Gabrilovac .
Medical Oncology, 2012, 29 :561-569
[22]   Role of serum matrix metalloproteinase-2 and-9 to predict breast cancer progression [J].
Patel, Suprava ;
Sumitra, G. ;
Koner, B. C. ;
Saxena, Alpana .
CLINICAL BIOCHEMISTRY, 2011, 44 (10-11) :869-872
[23]   Altered Serum Levels of Matrix Metalloproteinase-2,-9 in Response to Electroconvulsive Therapy for Mood Disorders [J].
Shibasaki, Chiyo ;
Takebayashi, Minoru ;
Itagaki, Kei ;
Abe, Hiromi ;
Kajitani, Naoto ;
Okada-Tsuchioka, Mami ;
Yamawaki, Shigeto .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 (09) :1-8
[24]   Matrix metalloproteinase-9 and-2 and tissue inhibitor of matrix metalloproteinase-2 in invasive pituitary adenomas A systematic review and meta-analysis of case-control trials [J].
Liu, Hong-Yan ;
Gu, Wei-Jun ;
Wang, Cheng-Zhi ;
Ji, Xiao-Jian ;
Mu, Yi-Ming .
MEDICINE, 2016, 95 (24)
[25]   The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation [J].
Paju, A ;
Sorsa, T ;
Tervahartiala, T ;
Koivunen, E ;
Haglund, C ;
Leminen, A ;
Wahlström, T ;
Salo, T ;
Stenman, UH .
BRITISH JOURNAL OF CANCER, 2001, 84 (10) :1363-1371
[26]   The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation [J].
A Paju ;
T Sorsa ;
T Tervahartiala ;
E Koivunen ;
C Haglund ;
A Leminen ;
T Wahlström ;
T Salo ;
U-H Stenman .
British Journal of Cancer, 2001, 84 :1363-1371
[27]   Matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2, and transforming growth factor beta 1 in the aqueous humor and serum of patients with pseudoexfoliation syndrome [J].
Kara, Selcuk ;
Yildirim, Nilgun ;
Ozer, Ahmet ;
Colak, Omer ;
Sahin, Afsun .
CLINICAL OPHTHALMOLOGY, 2014, 8 :305-309
[28]   Expression and quantitative analysis of matrix metalloproteinase-2 and -9 in human gliomas [J].
Komatsu K. ;
Nakanishi Y. ;
Nemoto N. ;
Hori T. ;
Sawada T. ;
Kobayashi M. .
Brain Tumor Pathology, 2004, 21 (3) :105-112
[29]   Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer [J].
L Zhang ;
J Shi ;
J Feng ;
H Klocker ;
C Lee ;
J Zhang .
Prostate Cancer and Prostatic Diseases, 2004, 7 :327-332
[30]   The p75NTR metastasis suppressor inhibits urokinase plasminogen activator, matrix metalloproteinase-2 and matrix metalloproteinase-9 in PC-3 prostate cancer cells [J].
Angèle Nalbandian ;
Daniel Djakiew .
Clinical & Experimental Metastasis, 2006, 23
12345